India's Morepen makes first test batch of Russia's Sputnik V shot - fund

Morepen Laboratories

06/07/2021 09:00

MOSCOW, July 6 (Reuters) - Indian drug manufacturer Morepen
Laboratories has begun production of the Russian Sputnik V
coronavirus vaccine, the Russian Direct Investment Fund (RDIF),
responsible for marketing the shot internationally, said on
Tuesday. 
    The first test batch made by the Indian manufacturer in the
state of Himachal Pradesh will be shipped to Gamaleya, the
Moscow institute which developed the vaccine, for quality
controls, RDIF said in a statement.

 (Reporting by Polina Ivanova; Editing by Alex Richardson)
 ((olzhas.auyezov@thomsonreuters.com; +7 727 2508 500; Reuters
Messaging: olzhas.auyezov.thomsonreuters.com@reuters.net))